Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Braun TP. et al, (2022), Nat Commun, 13

To Bi or not to Bi: Acute Erythroid Leukemias and hematopoietic lineage choice.

di Genua C. and Nerlov C., (2021), Exp Hematol

Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing.

Valletta S. et al, (2020), Nat Commun, 11

Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.

Mello T. et al, (2020), Int J Cancer, 146, 3410 - 3422

C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.

Di Genua C. et al, (2020), Cancer Cell, 37, 690 - 704.e8

CD34 and EPCR coordinately enrich functional murine hematopoietic stem cells under normal and inflammatory conditions.

Rabe JL. et al, (2020), Exp Hematol, 81, 1 - 15.e6

Single-cell analysis of bone marrow-derived CD34+ cells from children with sickle cell disease and thalassemia.

Hua P. et al, (2019), Blood, 134, 2111 - 2115

Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.

Lopez CK. et al, (2019), Cancer Discov, 9, 1736 - 1753

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Braun TP. et al, (2019), Nat Commun, 10

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Braun T. et al, (2019), BLOOD, 134

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Braun T. et al, (2019), BLOOD, 134

Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.

Di Genua C. et al, (2019), Haematologica, 104, 2215 - 2224

Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging.

Ho Y-H. et al, (2019), Cell Stem Cell, 25, 407 - 418.e6

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.

Schmidt L. et al, (2019), Leukemia, 33, 1608 - 1619

Identification of two distinct pathways of human myelopoiesis.

Drissen R. et al, (2019), Sci Immunol, 4

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

Volpe G. et al, (2019), Life Sci Alliance, 2

Inflammatory signals directly instruct PU.1 in HSCs via TNF.

Etzrodt M. et al, (2019), Blood, 133, 816 - 819

Haematopoiesis in the era of advanced single-cell technologies.

Jacobsen SEW. and Nerlov C., (2019), Nat Cell Biol, 21, 2 - 8

Studying BDNF/TrkB Signaling: High-Throughput Microfluidic Gene Expression Analysis from Rare or Limited Samples of Adult and Aged Central Neurons

Nath AR. et al, (2019), Neuromethods, 143, 77 - 86

Studying BDNF/TrkB Signaling: Transcriptome Analysis from a Limited Number of Purified Adult or Aged Murine Brain Neurons

Vatanashevanopakorn C. et al, (2019), Neuromethods, 143, 55 - 76

Load More

1
2
3
4
5
6

Include forthcoming?